Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
28.42
+0.43 (1.54%)
May 12, 2026, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.69 billion as of May 12, 2026. Its market cap has increased by 0.16% in one year.
Market Cap
1.69B
Enterprise Value
680.44M
1-Year Change
0.16%
Ranking
Category
Stock Price
$28.42
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.69B, an increase of 83.92%. That is a compound annual growth rate of 4.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 1.66B | 4.87% |
| Dec 31, 2025 | 1.59B | -15.30% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
| Jul 24, 2013 | 919.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palvella Therapeutics | 1.74B |
| Viridian Therapeutics | 1.71B |
| Vericel | 1.71B |
| Nurix Therapeutics | 1.71B |
| Innoviva | 1.69B |
| Ardelyx | 1.67B |
| Nuvation Bio | 1.67B |
| Novavax | 1.66B |